biological source
rabbit
Quality Level
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen ~68 kDa
species reactivity
rat, human
enhanced validation
independent
Learn more about Antibody Enhanced Validation
concentration
~1.0 mg/mL
technique(s)
immunohistochemistry: 5-10 μg/mL using formalin-fixed paraffin embedded rat colon., indirect immunofluorescence: 2.5-5 μg/mL using HeLa cells., western blot: 1.5-3.0 μg/mL using using lysates of Jurkat cells.
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... FUS(2521)
rat ... Fus(317385)
General description
Fused in sarcoma (FUS) is a component of heterogeneous nuclear ribonucleoprotein (hnRNP) complex is a DNA/ RNA binding protein. FUS gene is mapped to human chromosome 16p11.2 and is located predominantly in the nucleus.
Immunogen
synthetic peptide corresponding to the N-terminal region of human FUS isoform 1, conjugated to KLH. The corresponding sequence is identical in human FUS isoforms 2 and 3, and highly conserved (single amino acid insertion) in mouse and rat FUS.
Application
Anti-FUS antibody produced in rabbit has been used in:
- immunohistochemistry
- immunoblotting
- immunofluorescence
Biochem/physiol Actions
Anti-FUS specifically recognizes human and rat FUS.
Fused in sarcoma (FUS) plays regulatory roles in transcription, RNA splicing and transport and is implicated in multiple diseases. FUS also called translocation in liposarcoma or Tumor lysis syndrome (TLS), plays a key role in DNA repair and transcriptional regulation. Chromosomal translocation of FUS/TLS is found in human cancers and results in the production of oncogenic FUS fusion proteins. FUS is a component of inclusion bodies in patients with Huntington′s disease (HD) and spinocerebellar ataxias (SCA1) and SCA3. Mutations in the FUS gene have been identified in amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FLTD) and familial amyotrophic lateral sclerosis (FALS). The majority of the FUS mutations have been identified in the C-terminal nuclear localization signal (NLS). Pathological FUS inclusions are mostly found in the cytosol of neurons and glial cells.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Preparation Note
For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Atypical Huntington?s disease with the clinical presentation of behavioural variant of frontotemporal dementia
Sutovsky S, et al.
Journal of neural transmission (Vienna, Austria : 1996), 123(12), 1423-1433 (2016)
TDP-43 and FUS: a nuclear affair
Dormann D and Haass C
Trends in Neurosciences, 34(7), 339-348 (2011)
Manuela Neumann et al.
Brain : a journal of neurology, 132(Pt 11), 2922-2931 (2009-08-14)
Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular basis. The neuropathology associated with most FTD is characterized by abnormal cellular aggregates of either transactive response DNA-binding protein with Mr 43 kDa (TDP-43) or tau protein. However, we
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SAB4200454-200UL | 04061838036414 |